El Hospital Universitario Basurto-Basurtuko Unibertsitate Ospitalea, más conocido como Hospital de Basurto, es un centro hospitalario público situado en el barrio homónimo de la villa de Bilbao, España.

During the past decade, Osi Bilbao-Basurto conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osi Bilbao-Basurto" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Osi Bilbao-Basurto" are "Rheumatoid Arthritis" (2 trials), "Arthritis" (1 trials), "Autoimmune Diseases" (1 trials), "Connective Tissue Diseases" (1 trials) and "EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC" (1 trials). Many other conditions were trialed in "Osi Bilbao-Basurto" in a lesser frequency.

Most popular intervention types in "Osi Bilbao-Basurto" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Placebo" (2 trials), "Atezolizumab" (1 trials), "Baricitinib" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osi Bilbao-Basurto" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Osi Bilbao-Basurto". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Osi Bilbao-Basurto, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osi Bilbao-Basurto, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".